Clalit Research Institute used an algorithm developed by Zebra Medical Vision capable of extracting useful biomarkers from chest CTs to augment existing cardiovascular disease prediction models in a way that would allow for better targeted treatment, less adverse outcomes, and lower healthcare costs.
Click here to read more.